Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate the safety of zalutumumab in combination with chemotherapy and radiotherapy as treatment of patients with head and neck cancer
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Genmab
NCT07124000 · Adenocarcinoma (NOS), Anal Cancer, and more
NCT04541381 · Gastrointestinal Cancer, Head and Neck Cancer, and more
NCT07209189 · Head and Neck Cancer, Squamous Cell Carcinoma, and more
NCT04389632 · Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, and more
NCT06477692 · Head and Neck Cancer
Oregon Health Sciences Center
Portland, Oregon
St-Luc University Hospital
Brussels
University Hospital Gasthuisberg
Leuven
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions